SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $352 | -43.9% | 200 | 0.0% | 0.00% | – |
Q4 2022 | $628 | -68.6% | 200 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -98.5% | 200 | -96.8% | 0.00% | -100.0% |
Q3 2019 | $67,000 | 0.0% | 6,267 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $67,000 | +11.7% | 6,267 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $60,000 | -18.9% | 6,267 | -2.9% | 0.00% | -33.3% |
Q4 2018 | $74,000 | -35.7% | 6,451 | -5.0% | 0.01% | -25.0% |
Q3 2018 | $115,000 | +15.0% | 6,789 | -7.7% | 0.01% | 0.0% |
Q2 2018 | $100,000 | -16.0% | 7,358 | +17.0% | 0.01% | -20.0% |
Q1 2018 | $119,000 | +65.3% | 6,288 | +42.8% | 0.01% | +66.7% |
Q4 2017 | $72,000 | +1340.0% | 4,403 | +1367.7% | 0.01% | +500.0% |
Q3 2017 | $5,000 | +66.7% | 300 | 0.0% | 0.00% | – |
Q2 2017 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |